Olivopontocerebellar Atrophy Clinical Trials

Find Olivopontocerebellar Atrophy Clinical Trials Near You

Ataxies SpinoCérébelleuses Autosomiques Dominantes et Cognition Sociale - Etude SoCoSca

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Spinocerebellar ataxias are a group of rare neurodegenerative diseases, clinically and genetically highly heterogeneous, with an estimated mean prevalence of 2.7 per 100,000 population. The term spinocerebellar ataxia or SCA is often used for ataxias of genetic origin of autosomal dominant transmission, which are the subject of this study. Recent studies of social cognition in patients with genetic cerebellar pathologies, and autosomal dominant spinocerebellar ataxia in particular, are still few and far between (around 15 studies), and seem to highlight impairment of basic emotion recognition and theory of mind skills. That said, data have very often been collected on very small samples of patients (sometimes in case study format). They also remain contradictory, including in the examination of the cerebellar anatomoclinical correlates of the deficits. Thus, the question arises as to whether patients with spinocerebellar ataxia also show impairments in emotion recognition and cognitive and affective theory of mind in more ecologically valid dynamic and interactive assessment situations.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:

⁃ For all participants:

• Men or women aged 18 and over

• At least 7 years' schooling (CEP level)

• Ability to read, write and speak French

• Signed informed consent to participate in the study

⁃ For patients :

⁃ \- With molecularly confirmed autosomal dominant spinocerebellar ataxia (SCA1, 2, 3, 6, 7, 27B)

⁃ For controls:

⁃ \- With no neurological pathology (questioning and neurological examination)

Locations
Other Locations
France
CHU Angers
RECRUITING
Angers
Contact Information
Primary
Philippe Allain, professor
phallain@chu-angers.fr
+33241355976
Time Frame
Start Date: 2025-12-09
Estimated Completion Date: 2029-01-01
Participants
Target number of participants: 160
Treatments
Active_comparator: patients autosomal dominant spinocerebellar ataxia
Active_comparator: healthy patients
Sponsors
Leads: University Hospital, Angers

This content was sourced from clinicaltrials.gov